Training activity information

Details

Produce an interpretive report on the suitability of potential HLA matched HSCT donor for clinical colleagues

Type

Entrustable training activity (ETA)

Evidence requirements

Evidence the activity has been undertaken by the trainee repeatedly, consistently, and effectively over time, in a range of situations. This may include occasions where the trainee has not successfully achieved the outcome of the activity themselves. For example, because it was not appropriate to undertake the task in the circumstances or the trainees recognised their own limitations and sought help or advice to ensure the activity reached an appropriate conclusion. ​

Reflection at multiple timepoints on the trainee learning journey for this activity.

Considerations

  • Local procedures and reporting in-line with current accreditation standards
  • Non-HLA factors
  • Integration of patient history and investigative results

Reflective practice guidance

The guidance below is provided to support reflection at different time points, providing you with questions to aid you to reflect for this training activity. They are provided for guidance and should not be considered as a mandatory checklist. Trainees should not be expected to provide answers to each of the guidance questions listed.

Before action

What does success look like?

  • Identify what is expected of you in relation to preparing an accurate and informative interpretive report that clearly communicates the suitability of a potential HLA matched HSCT donor.
  • Consider how the learning outcomes apply, specifically in relation to evaluating donor suitability, interpreting complex information, and communicating this effectively in a clinical report.
  • Discuss with your training officer to gain clarity of what is expected of you in relation to the typical format, content, and language required by clinical colleagues for an HSCT donor report.

What is your prior experience of this activity?

  • Think about what you already know about writing technical or interpretive reports for laboratory results, and if you are familiar with the format and content expected by clinical colleagues for an HSCT donor report.
  • Consider possible challenges you might face during the activity, such as ensuring clarity for a non-specialist audience or concisely including all necessary HLA matching information and potential risks.
  • Recognise the scope of your own practice for this activity i.e. know when you will need to seek advice or help, and from whom. You will need to seek advice from your Training Officer when required, for example if the HLA findings contradict the clinical request, or if specific reporting terminology or guidelines regarding allele-level resolution need clarification.
  • Acknowledge how you feel about the responsibility of providing critical information that will inform clinical decisions regarding transplantation.

What do you anticipate you will learn from the experience?

  • Consider the specific skills you want to develop, such as synthesising complex HLA and non-HLA donor information into a clinically relevant interpretive report structure.
  • Identify the specific insights you hope to gain into the information needs and priorities of clinical colleagues involved in Haematopoietic Stem Cell Transplantation (HSCT).

What additional considerations do you need to make?

  • Consult actions identified following previous experiences of drafting clinical reports or interpreting complex HLA data.
  • Identify important information you need to consider before embarking on the activity, such as the specific template or format used in your laboratory, the required details regarding HLA match grade and allele-level resolution, and the report review or authorisation process.

In action

Is anything unexpected occurring?

  • Are you noticing anything surprising or different from what you anticipate whilst producing an interpretive report on the suitability of a potential HLA matched HSCT donor for clinical colleagues?
  • Are you encountering situations such as:
    • The donor’s HLA typing or other relevant data requiring unexpected interpretation or clarification before reporting?
    • Difficulty structuring the report or phrasing specific findings clearly for a clinical audience while writing it?
    • Unexpected information (e.g., non-HLA data, previous testing results) that needs careful consideration for inclusion in the report?

How are you reacting to the unexpected development?

  • How is this impacting your actions? For example, are you responding to the situation appropriately? Are you adapting or changing your approach to interpreting the data or structuring the report?
  • Consider the steps you are taking in the moment, such as:
    • Consulting resources or colleagues during the reporting process because interpretation is difficult?
    • Adapting your writing style or referring to templates if phrasing is challenging?
  • How are you feeling in that moment? For instance, do you feel positive you can reach a successful conclusion? Is it affecting your confidence in completing the report confidently and independently?

What is the conclusion or outcome?

  • Identify how you are working within your scope of practice. For example, are you able to produce a clear and accurate interpretive report? Or are you needing support because you need to seek review before finalising the report?
  • What are you learning as a result of the unexpected development? For example, what are you learning in the moment about effectively communicating complex HLA and donor suitability information to clinicians?

On action

What happened?

  • Begin by summarising the key steps you took when producing the interpretive report on the suitability of a potential HLA matched HSCT donor for clinical colleagues.
  • Describe the specific HLA data you interpreted and how you structured the report for clinical colleagues.
  • Consider specific events, actions, or interactions which felt important, such as how you determined the final HLA match grade (e.g., 10/10) and structured the report to clearly present the non-HLA factors for the clinical team.
  • Include any ‘reflect-in-action’ moments where you had to adapt to the situation as it unfolded, for instance, immediately revising the phrasing used to describe a minor non-HLA discrepancy to ensure appropriate clinical context or pausing the writing process to consult the standard departmental template for required content.
  • How did you feel during this experience, e.g., did you feel focused on maintaining the factual integrity of the HLA data or stressed by the responsibility of ensuring clarity and accuracy in your communication?

How has this experience contributed to your developing practice?

  • Identify what learning you can take from this experience regarding interpreting donor suitability for reporting and effectively communicating findings to clinicians.
  • What strengths did you demonstrate, e.g., accurate application of HLA matching nomenclature in the report?
  • What skills and/or knowledge gaps were evident, e.g., difficulty translating complex HLA findings into concise clinical terminology or structuring the interpretive statement effectively?
  • Compare this experience against previous engagement with similar activities – were any previously identified actions for development achieved?
  • Has your practice improved in drafting reports that clearly address both HLA and non-HLA suitability criteria?
  • Identify any challenges you experienced, such as interpreting complex HLA findings or needing to seek review or clarification on scope of practice regarding the recommended follow-up or next steps, and how you reacted to this.

What will you take from the experience moving forward?

  • Identify the actions or ‘next steps’ you will now take to support the assimilation of what you have learnt, including from any feedback you have received, with regards to improving the clarity and clinical relevance of your interpretive reporting.
  • What will you do differently next time you approach producing an interpretive report on donor suitability, for instance, by proactively reviewing the latest clinical consensus on reporting donor CMV status?
  • Do you need to practise any aspect of the activity further, such as refining your interpretive writing or key learning outcomes related to effective communication?

Beyond action

Have you revisited the experiences?

  • How have your subsequent experiences of producing interpretive reports on HLA matched HSCT donors since completing this specific training activity led you to revisit your initial approach or decisions during that activity?
  • Considering what you understand about scientific writing, clinical reporting standards, and effective communication now, were the actions or considerations you identified after your initial reflection on this training activity sufficient?
  • How have you since implemented or adapted improvements in your report structure, terminology, and clarity of phrasing based on further learning and experiences? For example, how you proactively reviewed and integrated standardised templates for reporting complex allele-level resolution to ensure consistency and clarity for referring clinicians based on further learning.
  • Has discussing the interpretation and communication of complex HLA information or the impact of feedback from clinical colleagues who received your reports changed how you now view your initial experience in this training activity? For example, how professional storytelling with a senior colleague about a report where ambiguous phrasing led to confusion regarding a match grade refined your understanding of the critical nature of unambiguous professional communication.

How have these experiences impacted upon current practice?

  • How has the learning from this initial training activity, in combination with subsequent reporting experiences, contributed to your overall confidence and ability in translating complex HLA matching data into clear, concise, and clinically relevant interpretive reports for HSCT donors, particularly in preparing for assessments like DOPS or OCEs? For example, how your accumulated ability in synthesising technical data for a clinical audience now enables you to confidently prepare for observed assessments (DOPS or OCEs) such as ‘Present laboratory results for an HSCT case at a multidisciplinary meeting’ or ‘Advise a clinician on the likelihood of finding a suitable donor’ during an OCE assessment.
  • How has reflecting back on this specific training activity, combined with everything you’ve learned since, shaped your current approach to interpretive reporting?
  • How does this evolved understanding help you identify when a matched donor case involves subtle findings, requires nuanced reporting, or necessitates discussion of factors beyond standard HLA matching, and when this is beyond your scope of practice requiring expert review or clinical liaison?
  • Looking holistically at your training journey, how has this initial reporting experience, revisited with your current perspective, contributed to your development in meeting the learning outcomes related to interpreting complex information and evaluating donor suitability?

Relevant learning outcomes

# Outcome
# 1 Outcome

Apply the appropriate strategy for the investigation of patients being considered for haematopoietic stem cell transplantation (HSCT), interpret and report results of the investigation in the correct clinical context.

# 2 Outcome

Assess the suitability of potential related and unrelated matched and mismatched donors for HSCT.

# 3 Outcome

Perform clinical and laboratory monitoring of patients who have received HSCT.